Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Return on Capital Employed (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Return on Capital Employed for 3 consecutive years, with 0.54% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 6.0% to 0.54% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.54%, a 6.0% decrease, with the full-year FY2011 number at 0.3%, changed N/A from a year prior.
  • Return on Capital Employed was 0.54% for Q3 2025 at Lexicon Pharmaceuticals, down from 0.53% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.48% in Q3 2024 to a low of 0.54% in Q3 2025.